Grifols, S.A.
NASDAQ:GRFSDrug Manufacturers - General
+$0.03 today
- Market cap
- $7.17B
- Beta
- 1.17
- P/E (TTM)
- 14.7
- EPS (TTM)
- $0.61
- Dividend yield
- 1.67%
Volume 0.59M
Average 0.69M
GRFS Weighted Avg Shares
Average number of basic shares outstanding during the period, used to calculate basic EPS.
Grifols, S.A.NASDAQ: GRFS
Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026
Weighted avg shares declines year over year
Q2 FY2026 weighted avg shares of 680.58M shares fell 1.2% year over year, behind the -0.2% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +0.0% a year.
Context
- Weighted avg shares increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -1.2% toward the trailing-twelve-month pace of -0.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares history
Shares · from the income statement
- Latest · FY2025
- 680.58M EUR
- Year-over-year change
- +0.1%
- 4-year CAGR
- -0.0%
| Period | Period end | Weighted Avg Shares | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 680.58M | +0.1% |
| FY2024 | 2024-12-31 | 680.02M | +0.0% |
| FY2023 | 2023-12-31 | 679.76M | -0.0% |
| FY2022 | 2022-12-31 | 679.81M | -0.3% |
| FY2021 | 2021-12-31 | 681.56M | — |
Weighted Avg Shares vs competitors
How GRFS compares with its peers on the latest reported figures
- GRFS's LTM Jun 2026 weighted avg shares of 680.56M shares is the 2nd highest of the 9 companies compared; the peer median is 151.08M shares.
- Its year-over-year change of -0.2% is the 4th highest of 9, against a peer median of -0.6%.
- Over three fiscal years its annual growth of +0.0% compares with a peer median of -0.2%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | 1.74B | +0.1% | -0.1% | |
| LTM Jun 2026 | 680.56M | -0.2% | +0.0% | |
| LTM Sep 2026 | 278.36M | -3.4% | -0.9% | |
| LTM Jun 2026 | 235.22M | -1.0% | +6.4% | |
| LTM Sep 2026 | 156.12M | -0.3% | -0.3% | |
| LTM Jun 2026 | 146.04M | +2.7% | +3.3% | |
| LTM Mar 2026 | 67.93M | +1.0% | +6.1% | |
| LTM Jun 2026 | 46.49M | -6.3% | -2.4% | |
| LTM Jun 2026 | 26.9M | -3.2% | -2.9% | |
| Peer median (excluding GRFS) | 151.08M | -0.6% | -0.2% | |
Competitors are the stored peer set for GRFS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.93B | 6.06B | 6.59B | 7.21B | 7.23B |
| Cost of Revenue | 2.97B | 3.85B | 4.11B | 4.42B | 4.65B |
| Gross Profit | 1.96B | 2.21B | 2.48B | 2.79B | 2.58B |
| Gross Margin | 39.8% | 36.5% | 37.7% | 38.7% | 35.7% |
| Research & Development | 354.88M | 361.14M | 395.28M | 384.04M | 358.28M |
| Selling, General & Admin | 1.06B | 1.11B | 1.27B | 1.14B | 1.02B |
| Operating Expenses | 1.37B | 1.43B | 1.7B | 1.6B | 1.39B |
| Depreciation & Amortization | 359.77M | 410.98M | 446.42M | 437.9M | 432.24M |
| EBITDA | 944.03M | 1.19B | 1.17B | 1.48B | 1.62B |
| EBITDA Margin | 19.1% | 19.7% | 17.7% | 20.6% | 22.5% |
| Operating Income | 595.06M | 782.44M | 782.32M | 1.19B | 1.19B |
| Operating Margin | 12.1% | 12.9% | 11.9% | 16.5% | 16.4% |
| Interest Income | 11.55M | 33.86M | 62.43M | 48.05M | 32.66M |
| Interest Expense | 233.81M | 444.54M | 516.06M | 773.16M | 600.33M |
| Other Income / Expenses | (244.61M) | (444.42M) | (575.3M) | (748.02M) | (596.49M) |
| Income Before Tax | 350.45M | 338.01M | 207.02M | 444M | 590.73M |
| Pre-Tax Margin | 7.1% | 5.6% | 3.1% | 6.2% | 8.2% |
| Income Tax Expense | 85.13M | 90.11M | 43.35M | 231.19M | 110.46M |
| Net Income | 188.73M | 185.04M | 42.32M | 156.92M | 386.13M |
| Net Margin | 3.8% | 3.1% | 0.6% | 2.2% | 5.3% |
| EPS (Basic) | 0.27 | 0.31 | 0.09 | 0.23 | 0.57 |
| EPS (Diluted) | 0.27 | 0.31 | 0.09 | 0.23 | 0.57 |
| Weighted Avg Shares | 681.56M | 679.81M | 679.76M | 680.02M | 680.58M |
| Weighted Avg Shares (Diluted) | 681.56M | 679.81M | 679.76M | 680.02M | 680.58M |
Grifols, S.A.
NASDAQ:GRFS
Intrinsic Alpha fair value
Locked
Current Price
$8.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.